IndiTreat test process
Following consultation with the doctor and/or oncologist (1), a biopsy of the patient’s primary tumor or a metastasis usually from the liver (2) is sent to 2cureX laboratories in Denmark or Germany.
2cureX generates thousands of copies called microtumors (3). Drugs and drug combinations are applied to the microtumors and their growth responses are monitored for typically up to 14 days (4). A report is sent to the oncologist detailing microtumor resistance and sensitivity to each treatment (5). Based on the report, the oncologist and doctor can make better informed treatment recommendations to the individual patient (6).
Safe transport of samples to 2cureX
We achieve the safe transport of viable biopsies through a continuous temperature-controlled chain from your clinic to our laboratories with 2cureX distribution partners. We will set up a conference call with you and your team to ensure the safe transport of the consignments.
Follow IndiTreat test results online
A comprehensive lab report will be available within approximately 14 working days after we receive the tumor sample at the 2cureX lab. The physician will be able to follow the output of the IndiTreat test through our password protected customer portal at www.IndiTreat.com.
Please contact 2cureX for more information
September 15, 2021 at 15:00 (CET)
Interview with CEO Fernando Andreu (organized by Mangold) Open participation. Details provided later.
September 23, 2021
CSO Ole Thastrup will speak at the conference “Week of Health and Innovation 2021” in Odense, Denmark
September 28, 2021
Redeye Medtech & Diagnostics Investor meeting
September 29, 2021
Mangold Investor Lunch